Patients usually remember their doctors.
Hospitals remember the technology behind every successful procedure.
That is where Stryker has built one of the strongest reputations in medical technology. Founded in 1941, the company has become a global leader in orthopaedics, robotic-assisted surgery, neurotechnology and medical devices, helping healthcare providers perform millions of procedures every year. As hospitals continue investing in digital technologies and artificial intelligence, Stryker is expanding beyond traditional medical equipment into intelligent surgical platforms designed to improve precision, efficiency and patient outcomes.
Financial Highlights (FY2025)
Business & Financial Performance
- Revenue (FY2025): US$25.1 billion
- Net Income (FY2025): US$3.2 billion
- Organic Sales Growth: More than 10%
- Operating Income (FY2025): US$4.9 billion
- Operating Cash Flow: Approximately US$5.0 billion
- Employees: 53,000+
Stryker delivered another year of double-digit organic growth, supported by strong demand across Orthopaedics, MedSurg and Neurotechnology. The company’s diversified product portfolio and continued investment in surgical robotics have positioned it among the fastest-growing large-cap medical technology companies.
Building The Future Of Modern Surgery
Healthcare innovation extends far beyond pharmaceuticals.
Increasingly, hospitals are investing in technologies that help surgeons perform procedures with greater precision, reduce recovery times and improve long-term patient outcomes.
Stryker has built its business around five major areas:
- Medical Devices
- Robotic Surgery
- Orthopaedics
- Neurotechnology
- Digital Healthcare
Together, these businesses support more than 150 million patients annually, making Stryker one of the world’s most influential healthcare technology companies.
Robotic Surgery Is Becoming A Major Competitive Advantage
One of Stryker’s most important growth drivers is its Mako SmartRobotics platform.
Originally introduced for joint replacement procedures, the platform combines robotics, 3D imaging and data-driven surgical planning to improve precision during hip and knee replacement surgeries.
Today, Mako systems are installed in more than 1,000 hospitals worldwide, and the company continues introducing new generations of the platform to expand robotic-assisted procedures across additional clinical applications. Recent product updates include a fourth-generation Mako platform, reinforcing robotics as a central pillar of Stryker’s long-term strategy.
Why Stryker Matters
Demand for healthcare continues to increase as populations age and chronic diseases become more common.
At the same time, hospitals are seeking technologies that improve efficiency, reduce complications and shorten recovery times.
Rather than focusing on drug development, Stryker has become a leader by supplying the equipment, implants, robotics and digital technologies that enable healthcare professionals to deliver safer and more precise surgical care across hospitals worldwide.
Strategic Expansion
Stryker continues investing in technologies expected to shape the future of surgery.
- Robotic-assisted surgery
- Artificial intelligence
- Orthopaedic implants
- Neurotechnology
- Medical imaging
- Digital healthcare
- Smart operating rooms
These investments reflect the company’s strategy of combining hardware, software and data to create increasingly connected surgical ecosystems.
Main Competitors
Stryker competes with several of the world’s largest medical technology companies, including:
- Medtronic
- Johnson & Johnson MedTech
- Zimmer Biomet
- Smith+Nephew
- Boston Scientific
Competition continues to intensify as companies invest heavily in robotic surgery, AI-enabled medical technologies and minimally invasive procedures.
What Investors Should Watch
Several long-term trends could shape Stryker’s future growth.
- Robotic surgery adoption
- Orthopaedics demand
- AI-enabled healthcare
- Neurotechnology expansion
- Digital operating rooms
- Hospital capital spending
- International growth
These trends are expected to support continued demand for advanced medical technologies as healthcare systems modernize around the world.
Market Snapshot
Company: Stryker Corporation
Founded: 1941
Headquarters: Portage, Michigan, United States
CEO: Kevin A. Lobo
Industry: Medical Technology
Employees: 53,000+
Revenue (FY2025): US$25.1 billion
Market Cap: ~US$122 billion
Official Website: https://www.stryker.com
